Concierge Bariatrics P.A.

Concierge Bariatrics P.A. in Ocala, Florida, operates under the medical direction of Dr. Reginald Griffin, a board-certified surgeon holding credentials from the American Board of Surgery and fellowships with both the American College of Surgeons and the American Society of Metabolic and Bariatric Surgery. The practice integrates surgical weight loss interventions with peptide-based metabolic therapies and primary care services, providing patients in Marion County with a continuum of weight management options that extend beyond the operating room. Dr. Griffin's dual expertise in bariatric surgery and metabolic medicine allows the clinic to address obesity through both procedural and pharmaceutical pathways, tailoring treatment intensity to individual patient profiles and health histories.

Concierge Bariatrics P.A. offers an extensive peptide therapy program with 7 different peptides available, including metabolic peptides including AOD-9604, Semaglutide, growth hormone secretagogues like Ipamorelin, and other specialized compounds. Treatment selection is individualized based on comprehensive health assessments and patient goals.

Dr. Griffin's surgical fellowship training through the American Society of Metabolic and Bariatric Surgery informs his approach to patient evaluation, ensuring that individuals considering peptide therapy receive the same thorough preoperative-style assessment used for surgical candidates. This includes detailed review of comorbid conditions such as type 2 diabetes, hypertension, sleep apnea, and fatty liver disease—factors that influence both peptide selection and expected outcomes. The clinic's primary care capabilities allow for ongoing management of these conditions alongside weight loss treatment, eliminating the need for patients to coordinate care across multiple providers. For patients who have previously undergone bariatric surgery at other facilities or through Dr. Griffin's practice, peptide therapy serves as an adjunct tool to address weight regain or to optimize hormonal balance during the post-surgical maintenance phase.

In-person consultations at the Ocala office include body composition analysis, metabolic panel review, and discussion of realistic weight loss timelines based on the selected peptide regimen. Patients typically begin with an initial consultation where Dr. Griffin reviews medical history, current medications, and weight loss goals to determine candidacy for peptide therapy versus surgical intervention. Follow-up visits are scheduled at intervals appropriate to the peptide prescribed—weekly for Semaglutide or Tirzepatide titration, monthly for growth hormone secretagogues—with adjustments made based on patient-reported tolerance and objective measures such as weight, waist circumference, and laboratory markers. The clinic provides education on self-administration techniques for subcutaneous injections and supplies patients with dosing schedules and reconstitution instructions for lyophilized peptides. Patients are instructed on recognizing adverse effects such as nausea, injection site reactions, or hypoglycemia, with clear protocols for contacting the clinic between scheduled visits.

Concierge Bariatrics P.A. maintains a 4.8-star rating across 36 Google reviews, with patient feedback frequently referencing the thoroughness of surgical consultations, the responsiveness of office staff to questions, and the clarity of pre- and post-procedure communication. The clinic's location in Ocala positions it as a regional resource for North Central Florida residents seeking bariatric expertise combined with peptide therapy options, offering an integrated model that addresses weight loss through both metabolic pharmacology and surgical anatomy. Dr. Griffin's fellowship credentials and board certification provide patients with access to a provider trained in the most current bariatric techniques while also remaining versed in emerging peptide applications for metabolic disease, a combination that distinguishes the practice within Florida's competitive weight loss medicine landscape.